Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPermnt Tsb 30 Regulatory News (73HR)

Share Price Information for Permnt Tsb 30 (73HR)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
73HR Live PriceLast checked at - London Stock Exchange

Intraday Permnt Tsb 30 Share Chart

Repurchase Contingent Convertible Notes

23 Apr 2015 07:00

RNS Number : 0593L
Permanent TSB Group Holdings PLC
23 April 2015
 



headline: permanent tsb Group Holdings PLC announces the repurchase of €400m 10% contingent Convertible notes from the irish state

Update

Pursuant to the recent announcements in respect of its capital plans, permanent tsb Group Holdings plc (the "Group") today announces that it has agreed terms for the repurchase of the €400m 10% Contingent Convertible Notes from the Irish State at a premium of €10.544m.

Transaction details

The repurchase will be contingent upon the successful execution of the previously announced forthcoming capital raise of €525m, consisting of €400m of new equity and €125m of an Additional Tier 1 instrument, to be raised from private investors. This, together with other capital measures will satisfy the capital shortfall identified in the adverse scenario of the 2014 Single Supervisory Mechanism Comprehensive Assessment (SSM CA).

The Group has agreed a clean price for the repurchase of 102.636, representing a premium payable of €10.544m in addition to the €400m principal and accrued interest.

The Directors consider, having consulted with the Group's ESM advisor Davy, that the terms of the transaction are fair and reasonable insofar as the shareholders are concerned.

Financial Effect

The net benefit to the Group is the saving of future interest payments of c.€49m offset by the premium of €10.544m.

In the Income Statement of the Group, as measured on an Effective Interest Rate basis under IFRS, this will be presented as an aggregate loss on repurchase of c.€52m in H1 2015, which is offset by future interest expense savings of c.€90m.

Background

The €400m 10% Contingent Convertible Notes were issued by the Group's subsidiary permanent tsb plc (ptsb) on 27 July 2011 following the conclusion of the Prudential Capital Assessment Review. The notes had an original term of 5 years and were due to mature on 28 July 2016.

The key terms and conditions of the Contingent Convertible Notes are detailed as follows:

· The coupon interest rate is fixed at 10% payable annually in arrears which can be increased to 18% if the Minister for Finance wishes to re market the notes;

· The notes are convertible into the ordinary shares of permanent tsb Group Holdings plc, the parent of ptsb, in the occurrence of a Conversion Event;

· Conversion Event is defined as the occurrence of 1) a Capital Deficiency Event where ptsb's core Tier 1 capital falls below 8.25% or the Central Bank of Ireland notifies ptsb, that it has determined that its financial and solvency condition is deteriorating in such a way that a Capital Deficiency Event is likely to occur in the short term and/or 2) a Non-Viability Event where the ECB determines that ptsb may become insolvent or unable to pay its debts as they fall due, as defined in the related Agency Deed.

 Rationale for repurchasing

The Contingent Convertible Notes do not count as qualifying capital for the purposes of the SSM CA unless they are converted to equity. Thus, the only circumstances in which the Contingent Convertible Notes could be utilised to address the capital shortfall would be by way of their conversion into Ordinary Shares (which could only occur in circumstances where a conversion event of such Contingent Convertible Notes had occurred and no such conversion event has occurred).

Any conversion of the Contingent Convertible Notes in those circumstances would also further increase the equity holding of the Irish State in the Group and could amount to a new injection of State aid.

In addition, repurchasing the Contingent Convertible Notes will significantly reduce the associated interest costs of the Group in 2015 and 2016 in respect of such Contingent Convertible Notes.

It is expected that the repurchase will be completed on the agreed terms without delay following the completion of the capital raise.

 

Ciarán Long

Group Secretary

 

 

Contact Details

Glen Lucken,

Group Chief Financial Officer

Tel: +353 1 669 5145

 

Media:

Ray Gordon

Gordon MRM

ptsb@gordonmrm.ie

Mobile +353 87 241737

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STREAELAADPSEAF
Date   Source Headline
1st Mar 20237:00 amRNSCommentary on 2022 Annual Financial Report
1st Mar 20237:00 amRNSAnnual Financial Report
17th Jan 202310:00 amRNSAppointment of Board Chairperson Designate
11th Nov 20227:00 amRNSTrading Statement
7th Nov 20227:30 amRNSUlster Bank Retail Business: Acquisition Completed
21st Sep 20224:00 pmRNSSale of Buy To Let Portfolio
4th Aug 202210:00 amRNSDirectorate Change
27th Jul 20227:00 amRNSCommentary on 2022 Half-Year Report
27th Jul 20227:00 amRNSHalf-year Report
22nd Jul 20228:01 amRNSCompetition clearance received on Ulster Bank deal
24th Jun 202212:40 pmRNSResult of EGM
24th Jun 202212:40 pmRNSResult of AGM
3rd May 20227:00 amRNSTrading Statement
31st Mar 20229:30 amRNSDirectorate Change
2nd Mar 20227:00 amRNSCommentary on 2021 Annual Financial Report
26th Jan 202212:00 pmRNSSuccession Plan for Board Chairman
17th Dec 20217:15 amRNSAcquisition of elements of Ulster Bank business
10th Nov 202110:00 amRNSSale of Loan Portfolio
28th Oct 20217:00 amRNSTrading Statement
28th Jul 20217:00 amRNSHalf-year Report
28th Jul 20217:00 amRNSCommentary on 2021 Half-Year Report
23rd Jul 20217:00 amRNSPotential acquisition: Certain Ulster Bank Assets
5th May 20217:00 amRNSTrading Statement
3rd Mar 20217:00 amRNSAnnual Financial Report
3rd Mar 20217:00 amRNSCommentary on 2020 Annual Financial Report
24th Feb 20217:00 amRNSRedemption of AT1 Securities
19th Feb 20217:05 amRNSStatement re: Ulster Bank Withdrawal from ROI
3rd Nov 20207:00 amRNSTrading Statement
27th Oct 20207:00 amRNSSale of Buy To Let Loan Portfolio
25th Sep 202010:00 amRNSAppointment of Interim CFO
4th Aug 20207:00 amRNSCommentary on Half-Year Report
4th Aug 20207:00 amRNSHalf-year Report
22nd Jun 202010:00 amRNSAppointment of Chief Executive Officer
14th May 20207:00 amRNSTrading Statement
26th Feb 20207:00 amRNSCommentary on Annual Financial Report
26th Feb 20207:00 amRNSAnnual Financial Report
6th Nov 20197:00 amRNSTrading Statement
29th Oct 20193:00 pmRNSDirectorate Change
24th Oct 20192:00 pmRNSChief Executive To Step Down During 2020
3rd Oct 201910:49 amBUSEarly Redemption(s)
12th Sep 20192:00 pmRNSSale of Non-Performing Loan Portfolio
26th Jul 20195:00 pmRNSHalf-year Report
25th Jul 20197:00 amRNS2019 Half Year Report Commentary
30th May 20192:00 pmRNSConclusion of Tracker Enforcement Investigation
27th Mar 20196:30 pmRNSAnnual Financial Report
29th Nov 20184:00 pmRNSSecuritisation of a Non-Performing Loan Portfolio
8th Nov 20187:00 amRNSTrading Statement
3rd Oct 201811:00 amRNSDirectorate Change
30th Aug 20188:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.